Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
about
Gender analysis of moxifloxacin clinical trialsSerum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats.Penetration of moxifloxacin into rat mandibular bone and soft tissue.Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.
P2860
Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@en
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@nl
type
label
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@en
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@nl
prefLabel
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@en
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@nl
P2093
P2860
P1476
Diffusion of oral and intraven ...... pharmacokinetic steady-state.
@en
P2093
Djabarouti S
Gordien JB
Landreau V
P2860
P304
P356
10.1179/JOC.2003.15.6.558
P577
2003-12-01T00:00:00Z